Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

Comparison of Various Pharmacologic Agents in the Management of Hemodynamically Significant Patent Ductus Arteriosus in Preterm: A Network Meta-Analysis and Risk-Benefit Analysis

Introduction: Various pharmacological treatments are available for preterm infants with patent ductus arteriosus (PDA), but their risks and benefits are controversial. This study aimed to identify the best treatment for PDA using network meta-analysis (NMA) and risk-benefit assessment (RBA). Methods...

Full description

Bibliographic Details
Main Authors: Sudarat Eursiriwan, Chusak Okascharoen, Sakda Arj-Ong Vallibhakara, Oraluck Pattanaprateep, Pawin Numthavaj, John Attia, Ammarin Thakkinstian
Format: Article
Language:English
Published: Karger Publishers 2022-10-01
Series:Biomedicine Hub
Subjects:
patent ductus arteriosus
preterm
hemodynamically significant patent ductus arteriosus
risk-benefit analysis
indomethacin
ibuprofen
acetaminophen
Online Access:https://www.karger.com/Article/FullText/526318

Internet

https://www.karger.com/Article/FullText/526318

Similar Items